Sponsor

Parc Sanitari Sant Joan de Déu

Clinical research sponsor

Published trials14
Recruiting shown1
Roles1
SourceClinicalTrials.gov

Clinical trials

14 shown
Effectiveness of a Digital Platform in Engagement and Prognosis of Patients in an Early Intervention Pychosis ProgrammeNCT06556251 · collaborator · 2024-09-18
RECRUITING
VR-based Avatar Therapy for Treatment of Auditory HallucinationsNCT06505564 · collaborator · 2024-03-01
UNKNOWN
Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum DisordersNCT06423651 · collaborator · 2022-09-01
UNKNOWN
Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf)NCT05358457 · collaborator · 2022-09-01
UNKNOWN
Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood BiomarkersNCT05603819 · collaborator · 2022-06-29
COMPLETED
Effectiveness and Cost-effectiveness of the Initial Medication Adherence InterventionNCT05026775 · collaborator · 2022-03-01
UNKNOWN
Application of UP for Transdiagnostic Treatment of Emotional Disorders for UHR for Psychosis PatientsNCT04929938 · collaborator · 2021-09-06
UNKNOWN
Effectiveness of the Combination of Water Aerobics and Metacognitive TrainingNCT05455593 · collaborator · 2021-08-02
UNKNOWN
Feasibility and Acceptability of a Complex Intervention to Improve Initial Medication AdherenceNCT05094986 · collaborator · 2020-11-01
COMPLETED
The Role of Personal Identity in Psychotic Symptoms: a Study With the Repertory Grid TechniqueNCT03820362 · collaborator · 2016-02-01
COMPLETED
Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief EvolutionNCT04429412 · collaborator · 2015-01-01
COMPLETED
Effectiveness of Meta-Cognitive Training (EMC) in People With Psychosis of Brief Evolution.NCT02340559 · collaborator · 2012-08-01
COMPLETED
Low Weight Heparin prOphylaxis for Placental-Mediated Complications of PrEgnancyNCT01388322 · collaborator · 2012-03-01
COMPLETED
Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal WomenNCT01573637 · collaborator · 2011-07-01
COMPLETED

Sponsor roles

collaborator14

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.